Pharmacological therapy for chronic heart failure
نویسندگان
چکیده
منابع مشابه
Stem cell therapy for chronic heart failure.
PURPOSE OF REVIEW The aim of this review was to discuss recent advances in clinical aspects of stem cell therapy in heart failure with emphasis on patient selection, stem cell types and delivery methods. RECENT FINDINGS Several stem cell types have been considered for the treatment of patients with heart failure. In nonischemic heart failure, transplantation of CD34 cells improved myocardial ...
متن کاملThe future of pharmacological therapy for heart failure.
Current pharmacological therapy for heart failure (HF) is based on improved understanding of the pathophysiological mechanisms of HF progression. In particular, inhibition of key activated neurohormonal systems (eg, the renin-angiotensin-aldosterone system) and the sympathetic nervous system has been the cornerstone of drug therapy for this condition. However, despite these major advances, many...
متن کاملCardiac resynchronization therapy in chronic heart failure.
Cardiac resynchronisation therapy (CRT) has emerged as a treatment option for patients with severe, drug-refractory heart failure and signs of intraventricular dyssynchrony. In clinical trials CRT reduced the overall mortality, improved symptoms, exercise tolerance, and left ventricular function, as compared with optimised medical therapy alone. One of the challenging fields in patient selectio...
متن کاملPharmacological Treatment of Heart Failure
Optimal treatment of heart failure is important to reduce hospitalization and mortality. In according to recommendation for treatment from major guideline, most patients with HF should be routinely managed with a combination of 3 types of drugs: a diuretic, an ACEI or an ARB, and a beta blocker. The value of these drugs has been established by the results of numerous large-scale clinical trials...
متن کاملCLINICAL REVIEW Cardiac resynchronisation therapy for chronic heart failure
Chronic heart failure is common, affecting about 900 000 people in theUnited Kingdom andwith a prevalence of about 6-10% in people aged over 65 years; despite modern drug treatment, it carries a high morbidity and a 10% annual mortality. About a third of patients with chronic heart failure have a left ventricular ejection fraction ≤35%, up to 40% of whom are at risk of worse outcomes and more s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Vnitřní lékařství
سال: 2018
ISSN: 0042-773X,1801-7592
DOI: 10.36290/vnl.2018.117